Streptomyces hygroscopicus

Streptomyces hygroscopicus

a soil organism isolated on Easter Island; the source of rapamycin.
References in periodicals archive ?
Rapamycin, an antifungal, anticancer, and immune-suppressing compound secreted by the bacterium Streptomyces hygroscopicus, is the basis for an anti-aging drug being developed by the Swiss pharmaceutical company Novartis.
Igarashi Y, T Iida R, Yoshida and T Furumai Pteridic acids A and B, novel plant growth promoters with auxin-like activity from Streptomyces hygroscopicus TP-A0451.
For example, rapamycin, an immune-suppressor used to prevent transplant rejection, is produced by the bacterium Streptomyces hygroscopicus.
Hygromycin B is a potent product of Streptomyces hygroscopicus that acts as an antibiotic against both prokaryotic and eukaryotic organisms (1), (2).
Sirolimus a macrocyclic lactone produced by Streptomyces hygroscopicus which is a potent immunosuppressive agent.
The active ingredient is pimecrolimus, which is derived from ascomycin, a natural substance produced by the fungus Streptomyces hygroscopicus var.
The drug is derived from the soil bacterium Streptomyces hygroscopicus, native to the island of Rapa Nui (Easter Island).
Sirolimus (Rapamune[R] rapamycin) is a macrocyclic lactone produced by Streptomyces hygroscopicus (1, 2).
tumefaciens) and bar (phosphinotricin acetyltransferase from Streptomyces hygroscopicus, another soil bacterium) with terminator 3'g7 (source unspecified) both under the control of the bidirectional TR1/2 promoter (from A.
Sirolimus was isolated in the 1970's from Streptomyces hygroscopicus in soil samples from Easter Island.

Full browser ?